• +91 8418 663000

Business Strategy

Business Strategy

Become a key global player in parenteral (oncological and non oncological) dosage form development, manufacturing and registrations.

Carefully select internal product portfolio based upon following important traits;

  • Competitive advantage
  • Develop novel, critical, difficult to make parenteral formulations
  • Para IV
  • Complex Para III products
  • 505(b)2 products
  • Maintain zero conflict of interest with clients

Business Models

Our business models are flexible enough to meet client requirements. We offer four different business models to our customers.

    Fee for service

  • Milestone based contract development

  • Dossier out-licensing

  • Upfront fee with profit sharing
  • Upfront fee without profit sharing

  • Out-licensing of products at POC (proof of concept) stage

  • Upfront fee with profit sharing
  • Upfront fee without profit sharing

  • Co-development

  • Split of expenses & profit sharing with pre-agreed %
Back to Top